Related by context. Frequent words. (Click for all words.) 62 Phase IIa clinical trials 62 unique PER.C6 ® 60 Panzem R 59 forodesine 59 phase IIb clinical 58 Phase IIb trials 58 non alcoholic steatohepatitis 58 sodium Injection 58 vernakalant oral 57 elotuzumab 57 R sorafenib tablets 57 investigational compounds 57 rNAPc2 57 ApoB SNALP 57 Allovectin 7 R 57 anticancer compounds 57 PEG SN# 57 Pivotal Phase 56 Fibrillex TM 56 ALN VSP 56 Presents Positive 56 Veronate 56 HGS ETR1 56 AVE# 55 Phase III clinical trials 55 L Annamycin 55 multi kinase inhibitor 55 VQD 55 BCX# 55 drug conjugate ADC 55 CK # novel 55 novel antibody therapeutics 55 Anturol 55 MOZOBIL 55 ALN TTR# 55 6R BH4 55 Ferumoxytol 55 oral calcitonin 55 IMC A# 55 TELCYTA 54 metastatic castration resistant 54 TOCOSOL Paclitaxel 54 preclinical compounds 54 squalamine 54 PRX # 54 MAP# 54 MEK inhibitor 54 MKC# 54 cancer immunotherapies 54 Rosetta dependence 54 Stedivaze 54 Phase 2a clinical 54 deforolimus 54 dose cohorts 54 bafetinib 54 Phase III Clinical Trial 54 non nucleoside polymerase 54 HCV protease inhibitor 54 immunological disorders 54 CR# vcMMAE 54 MGCD# [001] 53 Inc. Nasdaq IMGN 53 Pivotal Phase III 53 anticancer compound 53 Phase IIa trial 53 Genitope Corporation 53 By Thomas Gryta 53 relapsed refractory multiple myeloma 53 liposomal formulation 53 Metastatic Melanoma 53 GlaxoSmithKline Bristol Myers 53 registrational trial 53 LymphoStat B 53 Phase 2b clinical 53 MGCD# MGCD# [002] 53 Omigard 53 Phase Ib 53 SILENOR TM 52 NVA# 52 dose escalation trial 52 Phase 1b clinical 52 Phase 1b trial 52 CALAA 52 RGB # 52 relapsed multiple myeloma 52 Traficet EN 52 talactoferrin 52 Cloretazine R VNP#M 52 Onalta 52 OXi# 52 Phase 2b study 52 multicenter Phase 52 transcriptase inhibitor NNRTI 52 ecallantide 52 lymphoma CTCL 52 Azixa 52 CCX# 52 carcinoid syndrome 52 generation antisense 52 Synavive 51 KNS #